PDCD1 and neoplasm: Interferon-gamma (IFNG), which is an important cytokine for initiating and maintaining a potent anti-tumor response in multiple pathways, has been considered a useful predictor of response to anti-PD1/PDL1 therapy across various tumors (29, 37).